4Filing Date: Feb 23, 2026
Edwards Lifesciences (EW) 4: Lippis Daniel J. sold 432 shares of Common Stock at $79.78… (Feb 23, 2026)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001225208-26-002409
Total Value$34.5K
Trades1
Insiders1
Transaction Details
Lippis Daniel J.
CVP, TAVR·Direct
Tax W/H · Dispose
Common Stock
Shares-432
Price$79.78
Total Value$34.5K
Shares Owned After33.93K
Transaction DateFeb 22, 2026
Post-Transaction Holdings
Lippis Daniel J. · CVP, TAVR
| Security | Shares | Change |
|---|---|---|
| Common Stock | 33.93K | -432 (-1.26%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-02-22
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Edwards Lifesciences Corp (EW)
CIK: 0001099800
--- Reporting Owner ---
Name: Lippis Daniel J.
CIK: 0002004380
Role: Officer (CVP, TAVR)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-02-22 | Code: F (Payment of exercise/tax)
Shares: -432 | Price: $79.78
Total Value: $34,464.96
Shares Owned After: 33,933.9103 | Ownership: D (Direct)
--- Signature ---
/s/ Linda J. Park, Attorney-in-Fact (2026-02-23)